Aurora Cannabis (ACB) Capital Expenditures Growth (1y) (2018 - 2025)
Aurora Cannabis (ACB) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | -21.54% |
| 10 | Aurora Cannabis | 155.11 Mn | 69.87 Mn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1.04% |
| Dec 31, 2024 | -70.55% |
| Sep 30, 2024 | -6.65% |
| Dec 31, 2023 | 76.66% |
| Sep 30, 2023 | 60.75% |
| Dec 31, 2022 | 2.21% |
| Sep 30, 2022 | -80.28% |
| Jun 30, 2022 | -105.99% |
| Mar 31, 2022 | 47.97% |
| Dec 31, 2021 | 16.15% |
| Sep 30, 2021 | 62.71% |
| Jun 30, 2021 | 415.35% |
| Mar 31, 2021 | 84.65% |
| Dec 31, 2020 | 89.04% |
| Sep 30, 2020 | 85.63% |
| Jun 30, 2020 | 95.04% |
| Mar 31, 2020 | -186.07% |
| Dec 31, 2019 | -264.56% |
| Sep 30, 2019 | -249.36% |
| Jun 30, 2019 | -371.66% |